Tc17 cells in autoimmune diseases.
10.1097/CM9.0000000000002083
- Author:
Yong PENG
1
;
Xiang DENG
1
;
Qiuming ZENG
2
;
Yandan TANG
1
Author Information
1. Department of Neurology, Affiliated First Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, Hunan 412000, China.
2. Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Mice;
Encephalomyelitis, Autoimmune, Experimental;
Th17 Cells;
CD8-Positive T-Lymphocytes/metabolism*;
CD4-Positive T-Lymphocytes/metabolism*;
Multiple Sclerosis/metabolism*;
Mice, Inbred C57BL
- From:
Chinese Medical Journal
2022;135(18):2167-2177
- CountryChina
- Language:English
-
Abstract:
Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), a pathologically similar disease used to model MS in rodents, are typical CD4+ T cell-dominated autoimmune diseases. CD4+ interleukin (IL)17+ T cells (Th17 cells) have been well studied and have shown that they play a critical role in the pathogenesis of MS/EAE. However, studies have suggested that CD8+IL17+ T cells (Tc17 cells) have a similar phenotype and cytokine and transcription factor profiles to those of Th17 cells and have been found to be crucial in the pathogenesis of autoimmune diseases, including MS/EAE, psoriasis, type I diabetes, rheumatoid arthritis, and systemic lupus erythematosus. However, the evidence for this is indirect and insufficient. Therefore, we searched for related publications and attempted to summarize the current knowledge on the role of Tc17 cells in the pathogenesis of MS/EAE, as well as in the pathogenesis of other autoimmune diseases, and to find out whether Tc17 cells or Th17 cells play a more critical role in autoimmune disease, especially in MS and EAE pathogenesis, or whether the interaction between these two cell types plays a critical role in the development of the disease.
